787359005: Romosozumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Sclerostin inhibitor\Romosozumab

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Monoclonal antibody\Romosozumab

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Romosozumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Romosozumab

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Romosozumab
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Romosozumab
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Romosozumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3775059018 Romosozumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3775060011 Romosozumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

369341000195111 romosozumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

1136901000241116 romosozumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Romosozumab	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Sclerostin inhibitor	true	Inferred relationship	Some
Romosozumab	Is a	Sclerostin inhibitor	true	Inferred relationship	Some
Romosozumab	Is a	Monoclonal antibody	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing romosozumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Romosozumab	Inferred relationship	Some	1
Product containing only romosozumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Romosozumab	Inferred relationship	Some	1
Product containing romosozumab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Romosozumab	Inferred relationship	Some	1
Product containing only romosozumab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Romosozumab	Inferred relationship	Some	1
Product containing precisely romosozumab 90 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Romosozumab	Inferred relationship	Some	1
Product containing precisely romosozumab 90 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Romosozumab	Inferred relationship	Some	1

This concept is not in any reference sets